0001209191-18-006131.txt : 20180131 0001209191-18-006131.hdr.sgml : 20180131 20180131083940 ACCESSION NUMBER: 0001209191-18-006131 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180123 FILED AS OF DATE: 20180131 DATE AS OF CHANGE: 20180131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene Alpine Investment Co., LLC CENTRAL INDEX KEY: 0001581774 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 18561092 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: X1 ZIP: 07901 BUSINESS PHONE: 908-673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: X1 ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene Switzerland LLC CENTRAL INDEX KEY: 0001661486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 18561093 BUSINESS ADDRESS: STREET 1: AON HOUSE STREET 2: 30 WOODBOURNE AVENUE CITY: PEMBROKE STATE: D0 ZIP: HM 08 BUSINESS PHONE: 4412964803 MAIL ADDRESS: STREET 1: AON HOUSE STREET 2: 30 WOODBOURNE AVENUE CITY: PEMBROKE STATE: D0 ZIP: HM 08 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celgene European Investment Co LLC CENTRAL INDEX KEY: 0001577650 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 18561091 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 908-673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36014 FILM NUMBER: 18561094 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGIOS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001439222 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-649-8600 MAIL ADDRESS: STREET 1: 88 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2018-01-23 2018-01-23 0 0001439222 AGIOS PHARMACEUTICALS INC AGIO 0000816284 CELGENE CORP /DE/ 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 0001661486 Celgene Switzerland LLC AON HOUSE 30 WOODBOURNE AVENUE PEMBROKE D0 HM 08 BERMUDA 0 0 1 0 0001581774 Celgene Alpine Investment Co., LLC 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 0001577650 Celgene European Investment Co LLC 86 MORRIS AVENUE SUMMIT NJ 07901 0 0 1 0 Common Stock 2018-01-23 4 P 0 851154 67.00 A 1374599 D Common Stock 5343834 I See footnote This Form 4 Amendment is being submitted to correct the date of earliest transaction in box 3 to reflect January 23, 2018. Of these shares, 624,575 shares are owned directly by Celgene Switzerland LLC, 708,333 shares are owned directly by Celgene Alpine Investment Co. LLC, and 4,010,926 shares are owned directly by Celgene European Investment Company LLC, each a wholly-owned subsidiary of Celgene Corporation ("Celgene"), and Celgene has the power to vote, acquire, hold and dispose of all such shares. Celgene disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. /s/Peter N. Kellogg, Executive Vice President and Chief Financial Officer, Celgene Corporation 2018-01-25 /s/ Kevin Mello, Manager, Celgene Switzerland LLC 2018-01-25 /s/ Kevin Mello, Manager, Celgene Alpine Investment Co., LLC 2018-01-25 /s/ Kevin Mello, Manager, Celgene European Investment Co., LLC 2018-01-25